naringenin has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bansal, S; Chopra, K; Kuhad, A; Kumar, A; Singh, P | 1 |
| Abuohashish, HM; Ahmed, MM; Al-Hosaini, AA; Al-Rejaie, SS; Aleisa, AM; Ola, MS; Parmar, MY | 1 |
2 other study(ies) available for naringenin and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Naringenin ameliorates diabetic neuropathic pain by modulation of oxidative-nitrosative stress, cytokines and MMP-9 levels.
Topics: Analgesics; Animals; Cytokines; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Flavanones; Matrix Metalloproteinase 9; Neuralgia; Oxidative Stress; Pain Measurement; Phytotherapy; Random Allocation; Rats; Rats, Wistar; Streptozocin | 2020 |
Naringenin neutralises oxidative stress and nerve growth factor discrepancy in experimental diabetic neuropathy.
Topics: Animals; Blood Glucose; Cytokines; Diabetic Neuropathies; Disease Models, Animal; Flavanones; Insulin; Male; Nerve Growth Factor; Oxidative Stress; Pain Threshold; Rats; Rats, Wistar; Reactive Oxygen Species; Sciatic Nerve; Streptozocin | 2015 |